Wyoming Attorney General Keith Kautz has determined that the medical cannabis rescheduling won't apply to his state.

The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion from the hearing process.

Formal hearings on marijuana's status under federal law before a top DEA judge concluded on Wednesday on a positive note, observers said.

The DEA has begun an administrative hearing to place marijuana in Schedule III of the Controlled Substances Act, which would make it easier to study, but would not change the criminal penalties or ...

A group of conservative activists Wednesday registered objections to the federal rescheduling of marijuana with the Alabama ...

May 12, 2026 - On April 23, 2026, the U.S. Department of Justice (DOJ) and U.S. Drug Enforcement Administration (DEA) announced the issuance of a final order, opens new tab (Order), signed by Acting ...

In December 2025, the Trump administration accelerated the process of reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act—a shift that would reduce restrictions ...

Federal cannabis rescheduling could bring financial changes to the industry. Experts weigh in on implications, including tax removal and banking access. Next: Get access to a new market-moving chart ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP examine the dual developments over the federal government's cannabis rescheduling efforts, focusing on litigation in the D.C.

Tens of millions of Americans turn to cannabis products every week to try to ease their pain, calm their anxiety, get more sleep, help them cope with the side effects of chemotherapy, or just relax ...